Citius Oncology, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
CTOR on Nasdaq
Location
11 Commerce Drive, 1 St Floor, Cranford, NJ

There are no Buy or Sell transactions made by insiders since 10/6/2024

Citius Oncology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Leonard L. Mazur Chief Executive Officer, Director $11.3M Sep 19, 2025
Myron Z. Holubiak Secretary, Director $5.23M Sep 19, 2025
Myron Czuczman Chief Medical Officer $4.65M Sep 19, 2025
Jaime Bartushak Chief Financial Officer $4.65M Sep 19, 2025
Joel David Mayersohn Director $1.19M Sep 19, 2025
Eugene Myron Holuka Director $941K Sep 19, 2025
Carol Webb Director $941K Sep 19, 2025
Dennis M. Mcgrath Director $941K Sep 19, 2025
Suren G. Dutia Director $941K Sep 19, 2025
Robert Joseph Smith Director $888K Sep 19, 2025
Citius Pharmaceuticals, Inc. 10%+ Owner Aug 12, 2024
Xiaofeng Yuan Chief Executive Officer, Director, 10%+ Owner Oct 13, 2022
Brian Hartzband Director Oct 13, 2022
Cathy Jiang Director Oct 13, 2022
Dahe Zhang Chief Financial Officer, Director, 10%+ Owner Oct 13, 2022

Recent Insider Transactions by Companies or Individuals for Citius Oncology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.